Galectin Therapeutics (GALT) Depreciation & Amortization (CF) (2010 - 2017)
Galectin Therapeutics' quarterly Depreciation & Amortization (CF) came in at $1000.0 in Q1 2017, little changed year-on-year from $1000.0 in Q1 2016, and down 50.0% quarter-over-quarter from $2000.0 in Q4 2016.
Galectin Therapeutics has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $1000.0 in Q1 2017.
- For the quarter ending Q1 2017, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2017 stood at $1000.0 (down 85.71% YoY), and the FY2017 full-year result was $1000.0, down 85.71% from the prior year.
- Depreciation & Amortization (CF) for Q1 2017 stood at $1000.0, down from $2000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $3000.0 in Q1 2013, with the low at $1000.0 in Q4 2015.
- Average Depreciation & Amortization (CF) over 5 years is $2176.5, with a median of $2000.0 recorded in 2014.
- Year-over-year, Depreciation & Amortization (CF) jumped 200.0% in 2013 and sank 50.0% in 2015.
- Tracing GALT's Depreciation & Amortization (CF) over 5 years: stood at $3000.0 in 2013, then plunged by 33.33% to $2000.0 in 2014, then slumped by 50.0% to $1000.0 in 2015, then jumped by 100.0% to $2000.0 in 2016, then slumped by 50.0% to $1000.0 in 2017.
- The last three Depreciation & Amortization (CF) figures came in at $1000.0 (Q1 2017), $2000.0 (Q4 2016), and $2000.0 (Q3 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 1,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Jun 30, 2016 | 2,000.00 |
| Jun 30, 2016 | 2,000.00 |
| Mar 31, 2016 | 1,000.00 |
| Mar 31, 2016 | 1,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Jun 30, 2015 | 2,000.00 |
| Jun 30, 2015 | 2,000.00 |
| Mar 31, 2015 | 2,000.00 |
| Mar 31, 2015 | 2,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Mar 31, 2014 | 2,000.00 |
| Mar 31, 2014 | 2,000.00 |
| Dec 31, 2013 | 3,000.00 |
| Dec 31, 2013 | 3,000.00 |
| Sep 30, 2013 | 3,000.00 |
| Sep 30, 2013 | 3,000.00 |
| Jun 30, 2013 | 3,000.00 |
| Jun 30, 2013 | 3,000.00 |
| Mar 31, 2013 | 3,000.00 |
| Mar 31, 2013 | 3,000.00 |
| Dec 31, 2012 | 4,000.00 |
| Dec 31, 2012 | 4,000.00 |
| Sep 30, 2012 | 1,000.00 |
| Sep 30, 2012 | 1,000.00 |
| Jun 30, 2012 | 2,000.00 |
| Jun 30, 2012 | 2,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Dec 31, 2011 | 2,000.00 |
| Dec 31, 2011 | 2,000.00 |
| Sep 30, 2011 | 2,000.00 |
| Sep 30, 2011 | 2,000.00 |
| Jun 30, 2011 | 3,000.00 |
| Jun 30, 2011 | 3,000.00 |
| Mar 31, 2011 | 2,000.00 |
| Mar 31, 2011 | 2,000.00 |
| Dec 31, 2010 | 1,000.00 |
| Dec 31, 2010 | 1,000.00 |
| Sep 30, 2010 | 3,000.00 |
| Sep 30, 2010 | 3,000.00 |